
Banu Aygun
Pediatric Hematology Oncology
269-01 76th Avenue
Suite 255
New Hyde Park, NY 11040
Suite 255
New Hyde Park, NY 11040
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Coping Strategies and Social Support for Transition Readiness Among Youth With Sickle Cell Disease.
Journal: JAMA network open
Published: July 13, 2026
Recruitment and retention of young adults with sickle cell disease.
Journal: Health care transitions
Published: December 22, 2025
Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support.
Journal: Health care transitions
Published: December 22, 2025
Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Journal: JAMA network open
Published: November 17, 2025
Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study.
Journal: Pediatric blood & cancer
Published: October 17, 2025
HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell Disease.
Journal: Pediatric blood & cancer
Published: June 20, 2025
The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial.
Journal: JMIR research protocols
Published: December 03, 2024
Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.
Journal: Pediatric blood & cancer
Published: April 16, 2024
Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report.
Journal: Pediatrics
Published: March 27, 2024
Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: November 19, 2023
Reducing transfusion utilization for children with sickle cell anemia in sub-Saharan Africa with hydroxyurea: Analysis from the phase I/II REACH trial.
Journal: American journal of hematology
Published: October 24, 2023
Last Updated: 09/26/2026